Personal CFO Solutions LLC Grows Holdings in Cabot Co. (NYSE:CBT)

Personal CFO Solutions LLC increased its position in shares of Cabot Co. (NYSE:CBTFree Report) by 3.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,285 shares of the specialty chemicals company’s stock after buying an additional 137 shares during the period. Personal CFO Solutions LLC’s holdings in Cabot were worth $391,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CBT. Copeland Capital Management LLC grew its holdings in Cabot by 21.6% during the 4th quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company’s stock worth $69,521,000 after acquiring an additional 135,119 shares in the last quarter. Lightrock Netherlands B.V. acquired a new position in Cabot during the 4th quarter worth $6,228,000. Barclays PLC grew its holdings in Cabot by 103.9% during the 3rd quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company’s stock worth $12,699,000 after acquiring an additional 57,907 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Cabot during the 4th quarter worth $5,057,000. Finally, JPMorgan Chase & Co. grew its holdings in Cabot by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 355,334 shares of the specialty chemicals company’s stock worth $39,716,000 after acquiring an additional 41,554 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CBT. JPMorgan Chase & Co. decreased their price objective on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, February 21st. Mizuho decreased their price target on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a report on Tuesday, January 7th. Finally, StockNews.com raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Cabot currently has an average rating of “Hold” and a consensus price target of $97.00.

View Our Latest Analysis on CBT

Cabot Stock Up 0.9 %

CBT stock opened at $84.84 on Monday. Cabot Co. has a 52-week low of $79.57 and a 52-week high of $117.46. The company’s 50 day simple moving average is $87.48 and its 200-day simple moving average is $100.13. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. The firm has a market capitalization of $4.60 billion, a P/E ratio of 11.27, a P/E/G ratio of 0.74 and a beta of 1.21.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, equities research analysts anticipate that Cabot Co. will post 7.57 EPS for the current year.

Cabot Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date is Friday, February 28th. Cabot’s payout ratio is 22.84%.

Cabot declared that its board has approved a stock buyback plan on Tuesday, December 3rd that authorizes the company to buyback 10,000,000 shares. This buyback authorization authorizes the specialty chemicals company to purchase shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board of directors believes its shares are undervalued.

Cabot Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.